Radiofrequency ablation of colorectal liver metastases: Long-term survival? [1]

Acta Radiologica

Volumn 49, Issue 1, 2008, Pages 19-20

  Lopez Ben, S ^a,b   Figueras, J ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b General Surgery Department   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; CATHETER ABLATION; COLORECTAL TUMOR; FEMALE; HUMAN; INTERVENTIONAL RADIOLOGY; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; NOTE; PATHOLOGY; POSTOPERATIVE COMPLICATION; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RADIOGRAPHY, INTERVENTIONAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 38349119160     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850701697408     Document Type: Letter

References (11)

1. Sørensen SM, Mortensen FV, Nielsen DT. Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 2007;48:253-8.
2. Figueras J, Torras J, Valls C, Liado L, Ramos E, Martin-Raguè J, et al. Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients. Dis Colon Rectum 2007;50:478-8.
3. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230:309-18.
4. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000;231:487-99.
5. Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, Bonham AC, et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 1999;189:291-9.
6. Elias D, Sideris L, Pocard M, de Baere T, Dromain C, Lasau N, et al. Incidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy (and not treated when performing percutaneous radiofrequency ablation). Ann Surg Oncol 2005;12: 298-302.
7. Figueras J, Planellas P, Albiol MT, Lopez-Ben S, Soriano J, Codina-Barreras A, et al., Role of intraoperative ultrasound and multidetector computed tomography in surgery for colorectal liver metastases: a prospective study (accepted for publication in Cirugia Española).
8. Jarnagin WR, Bach AM, Winston CB, Haan LE, Heffernan N, Loumeau T, et al. What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease? J Am Coll Surg 2001;192:577-83.
9. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-42.
10. Folprecht G, Grothey A, Alberts S, Raab HR, Höhne CH, Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005;16:1311-9.
11. Wagner JS, Adson MA, Van Heerden JA, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer. Ann Surg 1984;199:502-7.